Premier Alternatives

Rila Therapeutics

South San Francisco, CA · Founded 2021 · Privately Held (backing)

Operator of a biotherapeutics company intended to address the burden of chronic fibrotic diseases. Rila Therapeutics is based in South San Francisco, CA and was founded in 2021. It was valued at $60 million at its early-stage round in Jan 2025, the last priced event on record. It has raised $7 million across 1 recorded round; the latest was a $7 million early-stage round in Dec 2024.

PMV mark · valuation
$60.0M
Oct 2026
Priced at
its early-stage round
Jan 2025
Total raised
$7.0M
Last round
Early Stage VC
Dec 2024

Rila Therapeutics key facts

as of Oct 2026
  • Operator of a biotherapeutics company intended to address the burden of chronic fibrotic diseases.
  • Rila Therapeutics is valued at approximately $60.0M as of Oct 2026, set at its early-stage round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $7.0M across 1 recorded rounds; the latest was Early Stage VC ($7.0M) in Dec 2024.
  • Notable investors include ShangPharma Innovation, Shafa Invest.
  • Rila Therapeutics has filed 1 Form D with the SEC, most recently Jan 2025 ($7.0M sold to 3 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$60.0M

Valued at $60.0M at its early-stage round, Jan 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Rila Therapeutics with a free account
  • ·Watch Rila Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Rila Therapeutics funding rounds

1 rounds
Dec 2024Early Stage VC$7.0MSEC filing▮
Full funding history →

Who backs Rila Therapeutics

2
ShangPharma InnovationShafa Invest

Rila Therapeutics valuation

Rila Therapeutics was valued at $60 million at its early-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Rila Therapeutics raised?

Rila Therapeutics has raised $7 million across 1 recorded round since 2024. The largest was a $7 million early-stage round in Dec 2024.

Rila Therapeutics has filed 1 Form D with the SEC, most recently in Jan 2025 ($7 million sold to 3 investors).

Rila Therapeutics investors

2 investors are on record for Rila Therapeutics, including ShangPharma Innovation and Shafa Invest. The early-stage round in Dec 2024 drew 3 investors.

About Rila Therapeutics

Operator of a biotherapeutics company intended to address the burden of chronic fibrotic diseases. The company focuses on addressing the critical medical needs to treat renal fibrosis, and its program is a first-in-class small molecule allosteric inhibitor targeting kidney fibrosis, enabling the medical industry to improve the lives of patients suffering from renal fibrosis by providing a safe and effective anti-fibrotic therapy.

Sector
Healthcare
HQ
South San Francisco, CA, United States
Founded
2021
Employees
2
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.